Showing 541-550 of 2150 results for "".
Spotlight on Sleep: Beyond the Polysomnogram—Modern Approaches to Diagnosing Sleep Apnea
https://practicalneurology.com/diseases-diagnoses/sleep/beyond-the-polysomnogram-modern-approaches-to-diagnosing-sleep-apnea/35814/The evolution from in-laboratory polysomnography to flow-based home sleep apnea testing and, more recently, wearables reflects advancements in sleep technologies and a move toward patient-centered care.Advance Care Planning in Amyotrophic Lateral Sclerosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/advance-care-planning-in-amyotrophic-lateral-sclerosis/31809/Focusing on feelings, facts, and family is useful in shared decision making.Treatment of Functional Movement Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/treatment-of-functional-movement-disorder/31885/All members of the treatment team must provide a unified message to a patient with functional movement disorder for treatment success.Therapeutic Approaches to Neuromuscular Repeat Disorders: Facioscapulohumeral Muscular Dystrophy and Myotonic Dystrophy Type 1
https://practicalneurology.com/diseases-diagnoses/neuromuscular/therapeutic-approaches-to-neuromuscular-repeat-disorders-facioscapulohumeral-muscular-dystrophy-and-myotonic-dystrophy-type-1/32027/A promising pipeline of therapeutics target toxic RNA.Contemporary Challenges in the Recognition, Diagnosis, and Management of Progressive Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/contemporary-challenges-in-the-recognition-diagnosis-and-management-of-progressive-multiple-sclerosis/31974/There are many challenges associated with identifying the transition to secondary progressive multiple sclerosis.A Practical Approach to Selecting Patients for Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-practical-approach-to-selecting-patients-for-amyloid-targeting-treatments/36190/A review of the clinical criteria, key challenges, and future directions in selecting patients for amyloid-targeting treatments.- Editorial Board & Contributorshttps://practicalneurology.com/columns/practice-management/editorial-board-contributors/31072/January 2008 Issue of Practical Neurology Highlights Esteemed Editorial and Contributor TeamThe January 2008 issue of *Practical Neurology* underscores its commitment to delivering high-quality neurological insights through a distinguished editorial and contributor team. Dr. Stephen Gollomp, Chief o
- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0407-movemntdis-pdf/31190/Tardive Dyskinesia: Overview, Causes, and ManagementTardive dyskinesia (TD) represents a complex group of involuntary, repetitive movements primarily resulting from prolonged use of dopamine-receptor antagonists (DRAs), including both typical and atypical antipsychotic medications. TD is characteriz
- Will Subspecialty Certification Change Your View of Neuroimaging?https://practicalneurology.com/diseases-diagnoses/imaging-testing/pn1106-certification-pdf/31245/Neuroimaging Gains Subspecialty Status in NeurologyIn a significant advancement for neurological practice, neuroimaging has been officially recognized as a subspecialty by the United Council of Neurological Subspecialties (UCNS) in July 2006. This designation follows the American Society of Neuroima
- Searching for the Connections Between PFO, Stroke and Migrainehttps://practicalneurology.com/diseases-diagnoses/stroke/pn0406-pfo-pdf/31321/Patent Foramen Ovale: Implications for Stroke and Migraine ManagementRecent advancements in neurology have intensified the focus on patent foramen ovale (PFO), a heart defect present in approximately 40 million Americans. Although many individuals with PFO remain asymptomatic, emerging research sugg